Life Science Innovation
Committed to driving the transformation of biotechnology and empowering the development of innovative enterprises
Learn more

Investment in Life Science

With Global Horizon, Chinese Angle strategy, BOCG strives to support true innovation and disruptive technology of life science.

Learn More

One Team, Global Reach

Accumulated 100+ years’ experience and US$ 1+ billion proven record, the BOCG veteran team builds its office and franchise in Shenzhen, Shanghai, Hong Kong, Gothenburg of Sweden, and Boston and extensive networks and footprint in Greater China, Asia, USA and Europe.

Learn More

ESG Empowerment

A signatory to the UN PRI and committed to promoting sustainable development and impact investment

Learn More

Latest news

BOCG named a Top 10 Impact Investment Institution in 2023
Apr 18, 2024

China’s Best Impact Investments of the Year Awards were solemnly announced, with BOCG winning the “2023 For Good Award | Top 10 Impact Investment Institution”. Dr. Yanling Wen, Chief Medical Officer of BOCG, was invited to participate in a roundtable forum to discuss the challenges and opportunities of ESG impact investment in China.

Distinguished Experts Joining the Advisory Board of BOCG
Jun 3, 2024

Four well-achieved experts with industry, academic and clinical background respectively, have joined its Scientific and Industrial Advisory Board ("The Advisory Board") to strengthen its investment and operational capabilities. They are Dr. Yan Shao, Dr. Yongqin Zeng, Prof. Jixi Li and Prof. Yanling Wen.

Blue Ocean Capital Group becomes an official signatory to the United Nations-supported Principles for Responsible Investment
Jun 3, 2024

BOCG has become an official signatory to the United Nations-supported Principles for Responsible Investment ("UN PRI"). As one of the Chinese leading investment firms focusing on healthcare sector to join UN PRI, BOCG is committed to promoting responsible investment and empowering sustainable development of the portfolio companies.